Skip to main content
SpringerLink
Log in

Medical Therapy for Carotid Artery Stenosis

  • Chapter
Handbook Of Complex Percutaneous Carotid Intervention

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 864 Accesses

Abstract

Patients with carotid atherosclerotic disease are at an increased risk for stroke. This chapter reviews the risk factors associated with carotid artery stenosis and the medical interventions that decrease the cardiovascular risk from carotid atherosclerotic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325: 445–53.

    Google Scholar 

  2. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421–1428.

    Article  Google Scholar 

  3. Barnett HJ, Taylor DW, Eliaszi M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415–1425.

    Article  PubMed  CAS  Google Scholar 

  4. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491–1502.

    Article  PubMed  CAS  Google Scholar 

  5. Wilson PW, Hoeg JM, D’Agostino RB, et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997;337:516–522.

    Article  PubMed  CAS  Google Scholar 

  6. Mannami T, Baba S, Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000;160:2297–2303.

    Article  PubMed  CAS  Google Scholar 

  7. Duncan GW, Lees RS, Ojemann RG, David SS. Concomitants of atherosclerotic carotid artery stenosis. Stroke 1977;8:665–669.

    PubMed  CAS  Google Scholar 

  8. Bogousslavsky J, Regli F, Van Melle G. Risk factors and concomitants of internal carotid artery occlusion or stenosis. A controlled study of 159 cases. Arch Neurol 1985;42:864–867.

    PubMed  CAS  Google Scholar 

  9. Candelise L, Bianchi F, Galligoni F, et al. Italian multicenter study on reversible cerebral ischemic attacks: III-Influence of age and risk factors on cerebrovascular atherosclerosis. Stroke 1984;15:379–382.

    PubMed  CAS  Google Scholar 

  10. Crouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987;18:990–996.

    PubMed  CAS  Google Scholar 

  11. Crouse JR, 3rd, Tang R, Espeland MA, Terry JG, Morgan T, Mercuri M. Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation 2002;106:2061–2066.

    Article  PubMed  CAS  Google Scholar 

  12. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913.

    Article  PubMed  Google Scholar 

  13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.

    Article  Google Scholar 

  14. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–1501.

    Article  PubMed  CAS  Google Scholar 

  15. Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet 1998;352:1801–1807.

    Article  Google Scholar 

  16. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255–3264.

    Article  Google Scholar 

  17. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827–838.

    Article  PubMed  CAS  Google Scholar 

  18. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145–153.

    Article  PubMed  CAS  Google Scholar 

  19. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension 2001;38:E28–E32.

    Article  PubMed  CAS  Google Scholar 

  20. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782–788.

    Article  PubMed  CAS  Google Scholar 

  21. Braunwald E, Domanski MJ, Fowler SE, et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004;351:2058–2068.

    Article  PubMed  CAS  Google Scholar 

  22. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022–2031.

    Article  PubMed  CAS  Google Scholar 

  23. Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004;292:2217–2225.

    Article  PubMed  CAS  Google Scholar 

  24. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–2572.

    Article  PubMed  CAS  Google Scholar 

  25. Rothwell PM, Howard SC, Spence JD. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003;34:2583–2590.

    Article  PubMed  CAS  Google Scholar 

  26. Ford CS, Crouse JR, 3rd, Howard G, Toole JF, Ball MR, Frye J. The role of plasma lipids in carotid bifurcation atherosclerosis. Ann Neurol 1985;17:301–303.

    Article  PubMed  CAS  Google Scholar 

  27. van Merode T, Hick P, Hoeks PG, Reneman RS. Serum HDL/total cholesterol ratio and blood pressure in asymptomatic atherosclerotic lesions of the cervical carotid arteries in men. Stroke 1985;16:34–38.

    PubMed  Google Scholar 

  28. Johnsen SH, Mathiesen EB, Fosse E, et al. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromso study. Circulation 2005;112:498–504.

    Article  PubMed  CAS  Google Scholar 

  29. Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovasc Risk 1999;6:217–221.

    PubMed  CAS  Google Scholar 

  30. Iso H, Jacobs DR, Jr., Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;320:904–910.

    PubMed  CAS  Google Scholar 

  31. Tirschwell DL, Smith NL, Heckbert SR. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004;63:1868–1875.

    PubMed  CAS  Google Scholar 

  32. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 1994;309:11–15.

    PubMed  CAS  Google Scholar 

  33. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902–2909.

    Article  PubMed  CAS  Google Scholar 

  34. Plehn JF, Davis BR, Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 1999;99:216–223.

    PubMed  CAS  Google Scholar 

  35. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149–1158.

    Article  PubMed  CAS  Google Scholar 

  36. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425–1435.

    Article  PubMed  CAS  Google Scholar 

  37. Collins R, Armitage J, Parish S, Sleight P, Peto R. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757–767.

    Article  PubMed  CAS  Google Scholar 

  38. Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med 2003;163:669–676.

    Article  PubMed  CAS  Google Scholar 

  39. Bloomfield Rubins H, Davenpor J, Babikian V, et al. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 2001;103:2828–2833.

    PubMed  CAS  Google Scholar 

  40. Gertz K, Laufs U, Lindauer U, et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 2003;34:551–557.

    Article  PubMed  CAS  Google Scholar 

  41. Marti-Fabregas J, Gomis M, Arboix A, et al. Favorable outcome of ischemic stroke in patients pre-treated with statins. Stroke 2004;35:1117–1121.

    Article  PubMed  CAS  Google Scholar 

  42. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005;65:253–258.

    Article  PubMed  CAS  Google Scholar 

  43. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837–853.

    Article  Google Scholar 

  44. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Bmj 1998;317:703–713.

    Google Scholar 

  45. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274:155–160.

    Article  PubMed  CAS  Google Scholar 

  46. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232–236.

    Article  PubMed  CAS  Google Scholar 

  47. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349:1569–1581.

    Article  Google Scholar 

  48. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349:1641–1649.

    Article  Google Scholar 

  49. Eknoyan G, Levin N. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis 2002;39:S1–246.

    Article  Google Scholar 

  50. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovas-cular ischaemic events. The SALT Collaborative Group. Lancet 1991;338:1345–1349.

    Article  Google Scholar 

  51. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med 1991;325:1261–1266.

    Google Scholar 

  52. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044–1054.

    Article  PubMed  CAS  Google Scholar 

  53. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002;162:2197–2202.

    Article  PubMed  CAS  Google Scholar 

  54. Johnson ES, Lanes SF, Wentworth CE, 3rd, Satterfield MH, Abebe BL, Dicker LW. A metaregression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med 1999;159:1248–1253.

    Article  PubMed  CAS  Google Scholar 

  55. Hennekens CH. Update on aspirin in the treatment and prevention of cardiovascular disease. Am J Manag Care 2002;8:S691–S700.

    PubMed  Google Scholar 

  56. Cote R, Battista RN, Abrahamowicz M, Langlois Y, Bourque F, Mackey A. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med 1995;123:649–655.

    PubMed  CAS  Google Scholar 

  57. Lindblad B, Persson NH, Takolander R, Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke 1993;24:1125–1128.

    PubMed  CAS  Google Scholar 

  58. Goertler M, Blaser T, Krueger S, Lutze G, Wallesch CW. Acetylsalicylic acid and microembolic events detected by transcranial Doppler in symptomatic arterial stenoses. Cerebrovasc Dis 2001;11:324–329.

    Article  PubMed  CAS  Google Scholar 

  59. Taylor DW, Barnett HJ, Haynes RB, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet 1999;353:2179–2184.

    Article  PubMed  CAS  Google Scholar 

  60. Final report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research Group. N Engl J Med 1989;321:129–135.

    Google Scholar 

  61. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003;163:2006–2010.

    Article  PubMed  Google Scholar 

  62. Iso H, Hennekens CH, Stampfer MJ, et al. Prospective study of aspirin use and risk of stroke in women. Stroke 1999;30:1764–1771.

    PubMed  CAS  Google Scholar 

  63. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1–13.

    Article  PubMed  CAS  Google Scholar 

  64. The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group. Lancet 1987;2:1351–1354.

    Google Scholar 

  65. Bousser MG, Eschwege E, Haguenau M, et al. &quote;AICLA&quote; controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983;14:5–14.

    PubMed  CAS  Google Scholar 

  66. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. Stroke 1985;16:406–415.

    Google Scholar 

  67. Leonardi-Bee J, Bath PM, Bousser MG, et al. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke 2005;36:162–168.

    Article  PubMed  CAS  Google Scholar 

  68. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159–168.

    Article  PubMed  Google Scholar 

  69. Diener HC, Darius H, Bertrand-Hardy JM, Humphreys M. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). Int J Clin Pract 2001;55:162–163.

    PubMed  CAS  Google Scholar 

  70. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in throm-boembolic stroke. Lancet 1989;1:1215–1220.

    Article  PubMed  CAS  Google Scholar 

  71. Hass WK, Easton JD, Adams HP, Jr., et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989;321:501–507.

    PubMed  CAS  Google Scholar 

  72. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329–1339.

    Article  Google Scholar 

  73. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331–337.

    Article  PubMed  CAS  Google Scholar 

  74. Payne DA, Jones CI, Hayes PD, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 2004;109:1476–1481.

    Article  PubMed  CAS  Google Scholar 

  75. Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444–1451.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interventional Cardiology, Hillsboro Cardiology, Hillsboro, Oregon

    David S. Lee MD

Authors
  1. David S. Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiology, University of British Columbia, Vancouver, BC, Canada

    Jacqueline Saw MD

  2. Department of Interventional Cardiology, Instituto Nacional de Cardiología “Ignacio Chávez,”, Mexico City, Mexico

    J. Emilio Exaire MD

  3. Interventional Cardiology, Hillsboro Cardiology, Hillsboro, OR

    David S. Lee MD

  4. Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH

    Jay S. Yadav MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Lee, D.S. (2007). Medical Therapy for Carotid Artery Stenosis. In: Saw, J., Exaire, J.E., Lee, D.S., Yadav, J.S. (eds) Handbook Of Complex Percutaneous Carotid Intervention. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-002-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-002-7_2

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-605-4

  • Online ISBN: 978-1-59745-002-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation